Oligonucleotide

R&D

Partner Content

Novo Nordisk seeks to target heart disease with Cardior acqu...

Cardior CSO will speak at the Oligonucleotide Therapeutics and Delivery conference following announcement of a buyout by Novo Nordisk to enhance their

Partner Content

Partner Content

Register for the Oligonucleotide Therapeutics and Delivery C...

SAE Media Group is delighted to announce the 2nd Annual Conference Oligonucleotide Therapeutics & Delivery, taking place on the 21st and 22nd September 2022 in London, UK.

News

Young lonely man in a wheelchair on a balcony looking at the nature in the spring

Sarepta DMD rival PepGen files $115m IPO

Just days after dosing its first patient in a Duchenne muscular dystrophy trial, US biotech PepGen has pushed the button on an initial public offering (IPO).

Events